| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
PDZ and LIM domain 3 | 0.547 | 0.769 | 3.0E-07 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
laminin subunit alpha 4 | 0.682 | 0.577 | 1.4E-24 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
dystrobrevin alpha | 0.695 | 0.385 | 0.63 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
NRAS proto-oncogene, GTPase | 0.390 | 0.808 | 0.49 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
myozenin 2 | 0.716 | 0.308 | 1.6E-03 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
GATA zinc finger domain containing 1 | 0.736 | 0.385 | 0.43 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
nebulette | 0.650 | 0.692 | 1.8E-36 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
mitogen-activated protein kinase kinase 2 | 0.534 | 0.731 | 0.97 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
group | 0.300 | None | 0 | 0 | |||||||||||
|
galactosidase alpha | 0.537 | 0.769 | 1.00 |
|
group | 0.440 | None | 0.750 | 0 | 0 | 2010 | 2018 | ||||||||
|
glucosidase alpha, acid | 0.631 | 0.577 | 2.8E-18 |
|
group | 0.360 | limited | 0.857 | 1 | 0 | 1994 | 2018 | ||||||||
|
sarcoglycan delta | 0.641 | 0.615 | 2.1E-03 |
|
group | 0.580 | None | 0.900 | 0 | 0 | 1997 | 2015 | ||||||||
|
emerin | 0.542 | 0.731 | 0.93 |
|
group | 0.500 | None | 0.909 | 0 | 0 | 1998 | 2019 | ||||||||
|
crystallin alpha B | 0.515 | 0.731 | 2.2E-02 |
|
group | 0.500 | None | 0.929 | 0 | 0 | 2003 | 2019 | ||||||||
|
dystrophin | 0.423 | 0.923 | 1.00 |
|
group | 0.700 | None | 0.962 | 0 | 0 | 1993 | 2020 | ||||||||
|
desmoplakin | 0.514 | 0.808 | 1.00 |
|
group | 0.500 | None | 0.966 | 0 | 0 | 2002 | 2019 | ||||||||
|
transthyretin | 0.423 | 0.885 | 0.52 |
|
group | 0.500 | strong | 0.987 | 2 | 0 | 1986 | 2020 | ||||||||
|
protein tyrosine phosphatase non-receptor type 11 | 0.385 | 0.923 | 1.00 |
|
group | 0.330 | None | 1.000 | 2 | 0 | 2004 | 2019 | ||||||||
|
LIM zinc finger domain containing 2 | 0.751 | 0.308 | 5.1E-05 |
|
group | 0.310 | limited | 1.000 | 1 | 0 | 2015 | 2015 | ||||||||
|
myosin heavy chain 7 | 0.516 | 0.692 | 4.2E-16 |
|
group | 0.500 | strong | 1.000 | 1 | 0 | 2001 | 2019 | ||||||||
|
myocardin | 0.619 | 0.615 | 0.33 |
|
group | 0.300 | strong | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||
|
solute carrier family 22 member 5 | 0.608 | 0.731 | 5.3E-16 |
|
group | 0.350 | limited | 1.000 | 1 | 0 | 2002 | 2018 | ||||||||
|
receptor accessory protein 1 | 0.653 | 0.423 | 0.99 |
|
group | 0.300 | strong | 1.000 | 1 | 0 | 2012 | 2012 |